FDA Drug · D-0038-2027

Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC 100 Tablets: 0093-2204-01; NDC 500 Tablets: 0093-2204-05

Class II · Ongoing

Presence of Foreign Tablets/Capsules

Affected lots / codes — check yours against thisLot, expiry: [100 Tablets] Lots 8634085, 8635085, 8636085, exp 07/2027; [500 Tablets] Lot 8633085, exp 07/2027

Recalling firm: Teva Pharmaceuticals USA, Inc, Parsippany, NJ
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 240,448 cartons
Distribution: US Nationwide.
Recall initiated: September 29, 2026
Classified: October 13, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0038-2027%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →